BLISSGVS: Bliss GVS Pharma Limited has informed the Exchange about a Copy of the Newspaper Publication regarding SPECIAL WINDOW FOR RE-LODGEMENT OF TRANSFER REQUESTS OF PHYSICAL SHARES and SPECIAL DRIVE FOR UPDATION OF KYC & OTHER RELATED UPDATIONS TO PREVENT TRANSFER OF UNPAID/ UNCLAIMED DIVIDENDS TO IEPF.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has published newspaper advertisements (in The Economic Times, Free Press Journal, Maharashtra Times, and Navshakti) on August 8, 2025, informing shareholders about two SEBI-driven initiatives. The first is a Special Window from July 7, 2025 to January 6, 2026, allowing shareholders to re-lodge old physical share transfer requests (those rejected before April 1, 2019), which will now be processed only in demat mode. The second is a Special Drive under SEBI's 'Saksham Niveshak' 100-day campaign (July 28 – November 6, 2025) urging shareholders to update KYC details (PAN, bank account, address, mobile, specimen signature) to prevent unpaid/unclaimed dividends from being transferred to the Investor Education and Protection Fund (IEPF). The company's Registrar is MUFG Intime India Private Limited. Shareholders with physical share certificates and unclaimed dividends for FY2017-18 onwards are the key targets.
This is a routine compliance and shareholder-awareness communication, not a material business event. Shareholders holding physical shares or with unclaimed dividends should act promptly to update KYC and re-lodge transfer documents, or risk losing unclaimed dividends to the IEPF. No direct impact on stock price or business operations is expected.